Biological Activity
mTOR inhibitor. Inhibits tumor proliferation in vitro and in vivo. Inhibits VEGF-induced HUVEC proliferation in vitro, but does not affect tumor vascular permeability in mouse models. Immunosuppressant. Activates autophagy.
Technical Data
| M. Wt | 958.22 |
| Formula | C53H83NO14 |
| Storage | Store at -20°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 159351-69-6 |
| PubChem ID | 100926147 |
| InChI Key | HKVAMNSJSFKALM-GKUWKFKPSA-N |
| Smiles | [H][C@@]12CC[C@H]([C@@](O1)(C(C(N3CCCC[C@]3(C(O[C@@](CC([C@@H](/C=C([C@H]([C@H](C([C@@H](C[C@@H](/C=C/C=C/C=C([C@@H](OC)C2)C)C)C)=O)OC)O)C)C)=O)([C@@H](C[C@@H]4CC[C@H]([C@H](OC)C4)OCCO)C)[H])=O)[H])=O)=O)O)C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 95.82 | 100 | |
| ethanol | 95.82 | 100 |
Preparing Stock Solutions
The following data is based on the product molecular weight 958.22. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.04 mL | 5.22 mL | 10.44 mL |
| 5 mM | 0.21 mL | 1.04 mL | 2.09 mL |
| 10 mM | 0.1 mL | 0.52 mL | 1.04 mL |
| 50 mM | 0.02 mL | 0.1 mL | 0.21 mL |
Molarity Calculator
Reconstitution Calculator
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
Dilution Calculator
Product Datasheets
References
References are publications that support the products' biological activity.
Lane et al (2009) mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin.Cancer Res. 15 1612 PMID: 19223496
Sedrani et al (1998) Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant Proc. 30 2192 PMID: 9723437
Galluzzi et al (2017) Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat.Rev.Drug.Discov. PMID: 28529316
Keywords: Everolimus, supplier, mTOR, inhibitors, inhibits, immunosuppressants, RAD001, mTOR, Tocris Bioscience
